Matt Brown Show - Conversations That Power The Business World.
Matt Brown Show - Conversations That Power The Business World.
www.MattBrownShow.com
MBS524 - Creating the next wave of cancer therapeutics - Charles Theuer, CEO TraconPharma.com (Built in California #33)
44 minutes Posted Dec 9, 2022 at 10:00 pm.
0:00
44:24
Download MP3
Show notes

TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, Our lead product candidate, envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma. Our other product candidates are YH001, a CTLA-4 antibody that is in Phase 1/2 development for the treatment of sarcoma, TRC102, a small molecule that is in Phase 2 clinical development for the treatment of mesothelioma; TJ004309, a CD73 antibody that is in Phase 1 testing, that is being developed through a collaboration with I-Mab Biopharma; multiple bispecific antibody programs in preclinical development that are being developed through a collaboration with I-Mab Biopharma.

Get interviewed on the Matt Brown Show: www.mattbrownshow.com

Support the Show.